Abstract
Rheumatoid arthritis (RA) is characterized by chronic joint inflammation and associates with HLA-DRB1*04. The
Collagen IIp261-273-specific T cell repertoire in the peripheral blood of DR4+ patients at the onset of the disease
shows a restricted TCR-beta chain usage among which the most frequent is TRBV25.
To define whether this group of DR4-restricted collagen-specific shared T cell could represent markers of activesevere
disease and response to therapy, 90 subjects affected by early-RA were enrolled in the study; peripheral
blood mononuclear cells were cultured with or without the human collagen II peptide p261-273 and were examined
by immunoscope analysis for the usage of the previously identified shared TCR-beta chains.
We report that the presence of T cells carrying rearrangement TRBV25 associated with HLA-DR haplotype and
disease activity. HLA-DRB1* haplotypes 04–04, 04–01 and 04–11 were significantly associated with usage of
TRBV25, higher disease activity at the onset of disease and poor response to DMARDs.
Finally, the HLA-DRB1* haplotype appeared complementary with current serologic tools to predict good and poor
responders in a treat to target strategy. The data reported here offer clues to predict the course of the disease and
to foresee personalized treatments in RA patients.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
Lingua originale | English |
---|---|
pagine (da-a) | 2037-2045 |
Numero di pagine | 9 |
Rivista | EBioMedicine |
Volume | 2 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- ACPA
- Clonotypes
- Disease activity
- HLA-DRB1
- TRBV 25